Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Merck
McKinsey
Medtronic
Johnson and Johnson

Last Updated: December 6, 2021

DrugPatentWatch Database Preview

Patent: 8,735,359

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 8,735,359
Title:Combinations of modalities for the treatment of diabetes
Abstract: A method of treating, preventing, or delaying the progression of Type 1 diabetes mellitus by administering an effective amount of a fusion protein composition comprising a T-cell co-stimulation antagonist and a portion of an immunoglobulin molecule and an effective amount of a Type 1 diabetes autoantigen. The method includes, for example, administering a cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) molecule and a Type 1 diabetes autoantigen. Pharmaceutical compositions are also provided herewith.
Inventor(s): Orban; Tihamer (Brookline, MA)
Assignee: Orban Biotech LLC (Brookline, MA)
Application Number:13/534,571
Patent Claims:see list of patent claims

Details for Patent 8,735,359

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bristol-myers Squibb Company ORENCIA abatacept For Injection 125118 2005-12-23 ⤷  Free Forever Trial 2039-03-29
Bristol-myers Squibb Company ORENCIA abatacept Injection 125118 2011-07-29 ⤷  Free Forever Trial 2039-03-29
Bristol-myers Squibb Company ORENCIA abatacept Injection 125118 2016-06-07 ⤷  Free Forever Trial 2039-03-29
Bristol-myers Squibb Company ORENCIA abatacept Injection 125118 2017-03-30 ⤷  Free Forever Trial 2039-03-29
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Johnson and Johnson
Harvard Business School
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.